Prediction of boron concentrations in blood from patients on boron neutron capture therapy

被引:0
|
作者
Shibata, Y
Matsumura, A [1 ]
Yamamoto, T
Akutsu, H
Yasuda, S
Nakai, K
Nose, T
Yamamoto, K
Kumada, H
Hori, N
Ohtake, S
机构
[1] Univ Tsukuba, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan
[2] Japan Atom Energy Res Inst, Tokai, Ibaraki 3191195, Japan
关键词
boron neutron capture therapy; BSH; glioblastoma; prompt gamma ray analysis; radiation therapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In boron neutron capture therapy, blood boron concentration is the key factor to calculate radiation dose, however, blood sampling is difficult during neutron irradiation. Materials and Methods: The prediction of blood boron concentrations for BNCT treatment planning has been prospectively investigated using patient data obtained at first craniotomy after the infusion of a low dose of sodium undecahydroclosododecaborate. Results: The boron biodistribution data showed a biexponential pharmacokinetic profile. If the final boron concentration at 6 or 9 hours after the end of the infusion is within the 95% confidence interval of the prediction, direct prediction from biexponential fit will reduce the error of blood boron concentrations during irradiation to around 6%. Conclusion: Actual boron concentrations during BNCT were reasonably and accurately predictable from the test data.
引用
收藏
页码:5231 / 5235
页数:5
相关论文
共 50 条
  • [31] Boron neutron capture therapy for malignant gliomas
    Diaz, AZ
    Coderre, JA
    Chanana, AD
    Ma, RM
    ANNALS OF MEDICINE, 2000, 32 (01) : 81 - 85
  • [32] Recent developments in boron neutron capture therapy
    Kabalka, GW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (05) : 545 - 551
  • [33] Boron neutron capture therapy for glioblastoma multiforme
    van Rij, CM
    Wilhelm, AJ
    Sauerwein, WAG
    van Loenen, AC
    PHARMACY WORLD & SCIENCE, 2005, 27 (02): : 92 - 95
  • [34] Boron neutron capture therapy for glioblastoma multiforme
    Catharina M. van. Rij
    Abraham J. Wilhelm
    Wolfgang A. G. Sauerwein
    Arie C. van. Loenen
    Pharmacy World and Science, 2005, 27 : 92 - 95
  • [35] Reporting Dose in Boron Neutron Capture Therapy
    Sauerwein, Wolfgang A. G.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (03) : 192 - 194
  • [36] Experience of boron neutron capture therapy in Japan
    Kanda, K
    ADVANCES IN NEUTRON CAPTURE THERAPY, VOLS I AND II: VOL I: MEDICINE AND PHYSICS, VOL II: CHEMISTRY AND BIOLOGY, 1997, 1132 : A71 - A76
  • [37] Overview of Boron Neutron Capture Therapy in 2022
    Sauerwein, Wolfgang A. G.
    Ulcar, Miha
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (03) : 143 - 147
  • [38] Development of boron nanocapsules for neutron capture therapy
    Nakamura, H.
    Ueno, M.
    Ban, H. S.
    Nakai, K.
    Tsuruta, K.
    Kaneda, Y.
    Matsumura, A.
    APPLIED RADIATION AND ISOTOPES, 2009, 67 (7-8) : S84 - S87
  • [39] Boron detection from blood samples by ICP-AES and ICP-MS during boron neutron capture therapy
    Linko, S.
    Revitzer, H.
    Zilliacus, R.
    Kortesniemi, M.
    Kouri, M.
    Savolainen, S.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (08) : 696 - 702
  • [40] Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy
    Kawasaki, Riku
    Hirano, Hidetoshi
    Yamana, Keita
    Oshige, Ayano
    Nishimura, Kotaro
    Kono, Nanami
    Sanada, Yu
    Bando, Kaori
    Tabata, Anri
    Yasukawa, Naoki
    Azuma, Hideki
    Takata, Takushi
    Sakurai, Yoshinori
    Tanaka, Hiroki
    Suzuki, Minoru
    Tarutani, Naoki
    Katagiri, Kiyofumi
    Nagasaki, Takeshi
    Ikeda, Atsushi
    CHEMBIOCHEM, 2023, 24 (15)